PUBLISHER: The Business Research Company | PRODUCT CODE: 1686356
PUBLISHER: The Business Research Company | PRODUCT CODE: 1686356
Esophagoscopes and gastroscopes are specialized types of endoscopes designed for the examination of the esophagus, the muscular conduit linking the throat to the stomach, as well as the upper gastrointestinal tract, encompassing the esophagus, stomach, and the initial section of the small intestine. These instruments play a crucial role in diagnosing various gastrointestinal conditions, offering guidance for treatments, and enabling therapeutic procedures like polyp removal or stent placement.
The primary categories of esophagoscopes and gastroscopes include rigid, flexible, transnasal, and others. A rigid esophagoscope is a firm and unyielding medical tool utilized for esophageal examinations, providing visual access to the muscular tube connecting the throat to the stomach. These instruments find applications in conditions such as gastroesophageal reflux disease, ulcers, Barrett's esophagus, celiac disease, among others, and are employed in diverse healthcare settings like hospitals, ambulatory surgical centers, specialty clinics, diagnostic centers, and more.
The esophagoscopes and gastroscopes market research report is one of a series of new reports from The Business Research Company that provides esophagoscopes and gastroscopes market statistics, including esophagoscopes and gastroscopes industry global market size, regional shares, competitors with a esophagoscopes and gastroscopes market share, detailed esophagoscopes and gastroscopes market segments, market trends and opportunities and any further data you may need to thrive in the esophagoscopes and gastroscopes industry. This esophagoscopes and gastroscopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The esophagoscopes and gastroscopes market size has grown strongly in recent years. It will grow from $1.67 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to prevalence of gastrointestinal disorders, aging population, early detection and cancer screening, minimally invasive procedures.
The esophagoscopes and gastroscopes market size is expected to see strong growth in the next few years. It will grow to $2.3 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growth in outpatient endoscopy centers, patient demand for non-invasive procedures, advances in imaging and visualization, healthcare infrastructure development. Major trends in the forecast period include advancements in endoscopy technology, technological advancements, 3d imaging, artificial intelligence (AI) and image analysis.
The escalating prevalence of inflammatory bowel disease (IBD) is a key driver behind the expanding esophagoscope and gastroscope market. Inflammatory bowel disease represents a persistent condition characterized by inflammation in the digestive tract. Esophagoscopes and gastroscopes play a pivotal role in diagnosing and managing IBD, providing a means to visually inspect and monitor the gastrointestinal tract. For instance, as per a research article published in the Journal of the Canadian Association of Gastroenterology in March 2023, the projected incidence rate of inflammatory bowel disease in Canada is anticipated to climb from 825 per 100,000 in 2023 to 1075 per 100,000 in 2035. This substantial rise in IBD cases acts as a driving force for the esophagoscope and gastroscope market.100,000 in 2023 to 1075 per 100,000 in 2035. This substantial rise in IBD cases acts as a driving force for the esophagoscope and gastroscope markets.
The escalating incidence of esophageal cancer is anticipated to drive the growth of the esophagoscope and gastroscope market. Esophageal cancer refers to the development of cancerous cells in the esophagus, the tube responsible for transporting food and liquids from the throat to the stomach. Esophagoscopy and gastroscopy are crucial diagnostic procedures that aid in the early detection and assessment of esophageal cancer by visually inspecting the esophagus and stomach for abnormalities and obtaining tissue samples for biopsy as needed. For instance, as of January 2023, the American Cancer Society Inc. reported approximately 21,560 new cases of esophageal cancer diagnosed (17,030 in men and 4,530 in women), with approximately 16,120 reported deaths from esophageal cancer (12,920 in men and 3,200 in women) for the same year. This surge in esophageal cancer cases acts as a significant driver for the esophagoscope and gastroscope market.
Leading companies in the esophagoscopes and gastroscopes market are focusing on creating innovative products, such as flexible endoscopes, to strengthen their competitive position. A flexible endoscope is a medical device used to inspect internal organs, particularly the gastrointestinal tract, by employing a flexible tube with an attached camera. This design allows real-time image transmission and supports minimally invasive procedures. For example, in October 2024, Lumicell, a biotechnology company based in the United States, received a $400,000 Phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) to develop a new flexible endoscope aimed at diagnosing Barrett's esophagus. The proposed endoscopic imaging platform will use a combination of far infrared fluorescence and reflected light imaging to detect potentially cancerous lesions in real-time, with the goal of improving the early detection of esophageal adenocarcinoma (EAC). Traditional methods of diagnosing precancerous lesions involve endoscopy and random biopsies, which can be inefficient and delayed. Lumicell's technology aims to enhance diagnostic sensitivity, reduce reliance on resources, and enable immediate treatment of detected lesions.
In April 2023, Boston Scientific, a leading US-based biomedical engineering company, completed its acquisition of Apollo Endosurgery for $615 million. This strategic move is part of Boston Scientific's broader initiative to enhance its portfolio in the field of endoluminal surgery and endo-bariatric solutions. Apollo Endosurgery, a distinguished US-based manufacturer specializing in endoscopy devices and gastroscopic solutions, is now integrated into Boston Scientific's comprehensive offerings.
Major companies operating in the esophagoscopes and gastroscopes market are Medtronic PLC, FUJIFILM Corporation, Stryker Corporation, Boston Scientific Corporation, B Braun Melsungen AG, Olympus Corporation, HOYA Corporation, Smith & Nephew PLC, Ethicon Inc., Hologic Inc., Steris PLC, Teleflex Incorporated, Karl Storz SE & Co. KG, CONMED Corporation, Ambu A/S, Richard Wolf GmbH, SonoScape Medical Corporation, Vimex Endoscopy Sp. z o.o., Smart Medical Systems Ltd., Jedmed Instrument Co, Endomed Systems GmbH, Maxer Endoscopy GmbH, Surtex Instruments Limited, FENTEX medical GmbH, Machida Endoscope Co. Ltd., Aohua Endoscopy Co. Ltd., Zhejiang Shendasiao Medical Instrument Co. Ltd., Hangzhou Orient Medical Co. Ltd., Medical Device Depot Inc., Optec Endoscopy Systems GmbH.
North America was the largest region in the esophagoscopes and gastroscopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in esophagoscopes and gastroscopes report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the esophagoscopes and gastroscopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The esophagoscopes and gastroscopes market consists of sales of zoom gastroscopes, endoscopy balloons, needle-knives, isolated-tip knife Endo clips, guide wires, diagnostic gastroscopes and video gastroscopes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Esophagoscopes And Gastroscopes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on esophagoscopes and gastroscopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for esophagoscopes and gastroscopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The esophagoscopes and gastroscopes market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.